N-(1-(Cyclohexylamino)-2-methyl-1-oxopropan-2-yl)-4-(dimethylamino)-N-(6-(hydroxyamino)-6-oxohexyl)benzamide

ID: ALA4082838

Chembl Id: CHEMBL4082838

PubChem CID: 137646965

Max Phase: Preclinical

Molecular Formula: C25H40N4O4

Molecular Weight: 460.62

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)c1ccc(C(=O)N(CCCCCC(=O)NO)C(C)(C)C(=O)NC2CCCCC2)cc1

Standard InChI:  InChI=1S/C25H40N4O4/c1-25(2,24(32)26-20-11-7-5-8-12-20)29(18-10-6-9-13-22(30)27-33)23(31)19-14-16-21(17-15-19)28(3)4/h14-17,20,33H,5-13,18H2,1-4H3,(H,26,32)(H,27,30)

Standard InChI Key:  FKKLUBFOEZONEI-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4082838

    ---

Associated Targets(Human)

HDAC1 Tclin Histone deacetylase 1/2/3/6 (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780cisR (133 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAL-27 (814 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 460.62Molecular Weight (Monoisotopic): 460.3050AlogP: 3.49#Rotatable Bonds: 11
Polar Surface Area: 101.98Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 8.91CX Basic pKa: 3.45CX LogP: 3.16CX LogD: 3.14
Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.27Np Likeness Score: -0.64

References

1. Krieger V, Hamacher A, Gertzen CGW, Senger J, Zwinderman MRH, Marek M, Romier C, Dekker FJ, Kurz T, Jung M, Gohlke H, Kassack MU, Hansen FK..  (2017)  Design, Multicomponent Synthesis, and Anticancer Activity of a Focused Histone Deacetylase (HDAC) Inhibitor Library with Peptoid-Based Cap Groups.,  60  (13): [PMID:28574690] [10.1021/acs.jmedchem.7b00197]

Source